Assessing the cardiac safety of ebastine. Epilogue.
Roberts, D J
Assessing the cardiac safety of ebastine. Epilogue. [electronic resource] - Drug safety 1999 - 89-92 p. digital
Publication Type: Journal Article; Review
0114-5916
10.2165/00002018-199921001-00011 doi
Animals
Butyrophenones--adverse effects
Cation Transport Proteins
DNA-Binding Proteins
ERG1 Potassium Channel
Ether-A-Go-Go Potassium Channels
Histamine H1 Antagonists--adverse effects
Humans
Piperidines--adverse effects
Potassium Channel Blockers
Potassium Channels
Potassium Channels, Voltage-Gated
Torsades de Pointes--chemically induced
Trans-Activators
Transcriptional Regulator ERG
Assessing the cardiac safety of ebastine. Epilogue. [electronic resource] - Drug safety 1999 - 89-92 p. digital
Publication Type: Journal Article; Review
0114-5916
10.2165/00002018-199921001-00011 doi
Animals
Butyrophenones--adverse effects
Cation Transport Proteins
DNA-Binding Proteins
ERG1 Potassium Channel
Ether-A-Go-Go Potassium Channels
Histamine H1 Antagonists--adverse effects
Humans
Piperidines--adverse effects
Potassium Channel Blockers
Potassium Channels
Potassium Channels, Voltage-Gated
Torsades de Pointes--chemically induced
Trans-Activators
Transcriptional Regulator ERG